**About the Editor**

#### **Giorgio Gallinella**

Giorgio Gallinella, MD, PhD. Born on 20.06.1963. Full Professor of Microbiology at the Department of Pharmacy and Biotechnology at the University of Bologna, Italy. He is currently teaching Medical Microbiology in the Master Degree Program in Health Biology, and Microbiology and Vaccines in the Master Degree Program in Pharmaceutical Biotechnology. He obtained his Degree in Medicine and Surgery in 1989, a PhD in Microbiological Sciences in 1993, and a Medical Specialization Degree in Microbiology and Virology in 1997. In year 2000 he received the Abbott Murex Award, conferred by the European Society for Clinical Virology, for the original contribution in the field of virologic diagnosis. In his scientific activity, he has conducted research in the field of basic and clinical virology. A special interest has been devoted to the study of Parvovirus B19, both as a model system for research in basic virology, and also for its clinical implication as a human pathogenic virus. In this context, the research is mainly focused on the study of virus-cell interactions; the study of the pathogenesis and of the clinical and epidemiological aspects of infectious processes; the development of innovative methodologies and diagnostic assays; the development of novel antiviral drugs. He has organized the IX Parvovirus Workshop, Bologna, Italy, august 2002, and more recently, the XVIII Parvovirus Workshop, Rimini, Italy, June 2022.
